Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice.

Lymphocytic choriomeningitis virus (LCMV), strain WE, is a non-cytopathic RNA virus that is highly adapted to its natural host, the mouse. Acute infection of adult mice leads to generalized virus spread, followed by cytotoxic T lymphocyte-mediated virus clearance below the detection levels of conventional assays within 2-3 weeks. Indirect evidence had suggested that virus or viral antigen might persist in the immune mouse. Here we demonstrate LCMV-WE persistence at low levels after infection with 10(2) or 10(6) plaque-forming units, shown as viral genome, viral antigen, and replicative virus using sensitive in vitro and in vivo assays. The finding that LCMV-WE persists in the face of apparently intact immune responses resembles the situation in some viral (hepatitis B and C, HIV) and bacterial (tuberculosis, leprosy) infections in humans; the results are relevant to the understanding not only of other murine and human persistent viral infections but also of protective immunological memory by "infection immunity."

[1]  G. Mackaness.  The immunology of antituberculous immunity. , 2015, The American review of respiratory disease.

[2]  J. Larsen.  Studies on immunological tolerance to LCM virus. 9. Induction of immunological tolerance to the virus in the adult mouse. , 2009, Acta pathologica et microbiologica Scandinavica.

[3]  R M Zinkernagel,et al.  On immunological memory. , 2000, Annual review of immunology.

[4]  P. Klenerman,et al.  A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Zinkernagel,et al.  Induction of Protective Cytotoxic T Cell Responses in the Presence of High Titers of  Virus-neutralizing Antibodies: Implications for Passive and Active Immunization , 1998, The Journal of experimental medicine.

[6]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[7]  J. Hoofnagle,et al.  Hepatitis C: The clinical spectrum of disease , 1997, Hepatology.

[8]  P. Klenerman,et al.  A non-retroviral RNA virus persists in DNA form , 1997, Nature.

[9]  R M Zinkernagel,et al.  A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Zinkernagel,et al.  Correlation of tolerogenicity of a viral antigen with its immunogenicity. , 1997, Journal of immunology.

[11]  R. Zinkernagel,et al.  Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[13]  J. Christensen,et al.  Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. , 1996, Journal of immunology.

[14]  H. Pircher,et al.  On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Zinkernagel,et al.  Specific cytotoxic T cells eliminate cells producing neutralizing antibodies , 1996, Nature.

[16]  R. Zinkernagel,et al.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors , 1995, Journal of virology.

[17]  R. Ahmed,et al.  Bone marrow is a major site of long-term antibody production after acute viral infection , 1995, Journal of virology.

[18]  R. Ahmed,et al.  Cytotoxic T-cell memory without antigen , 1994, Nature.

[19]  Peter C. Doherty,et al.  Virus-specific CD8+ T-cell memory determined by clonal burst size , 1994, Nature.

[20]  R. Welsh,et al.  Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses , 1994, The Journal of experimental medicine.

[21]  R M Zinkernagel,et al.  Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. , 1993, Journal of immunology.

[22]  W. Britton.  3. Immunology of leprosy , 1993 .

[23]  R. Zinkernagel,et al.  Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen , 1992, The Journal of experimental medicine.

[24]  D. Gray,et al.  B-cell memory is short-lived in the absence of antigen. , 1991, Nature.

[25]  R. Zinkernagel,et al.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Webster,et al.  Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. , 1991, The Journal of general virology.

[27]  R M Zinkernagel,et al.  Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.

[28]  Rolf M. Zinkernagel,et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.

[29]  R. Ahmed,et al.  T cell memory. Long-term persistence of virus-specific cytotoxic T cells , 1989, The Journal of experimental medicine.

[30]  R. Ahmed,et al.  Immune therapy of a persistent and disseminated viral infection , 1987, Journal of virology.

[31]  Y. Matsuura,et al.  Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus. , 1985, Virus research.

[32]  A. McMichael,et al.  DECLINING T-CELL IMMUNITY TO INFLUENZA, 1977-82 , 1983, The Lancet.

[33]  T. Ebels,et al.  DOPAMINE-INDUCED ISCHEMIA , 1977, The Lancet.

[34]  J. Larsen.  On the induction of immunological tolerance to a self-reproducing antigen. , 1969, Immunology.

[35]  M. Volkert,et al.  THE PROVOCATION OF LATENT LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTIONS IN MICE BY TREATMENT WITH ANTILYMPHOCYTIC SERUM , 1968, The Journal of experimental medicine.

[36]  E Traub,et al.  A FILTERABLE VIRUS RECOVERED FROM WHITE MICE. , 1935, Science.

[37]  Barbara J. Culliton,et al.  A year in the life of biomedical research , 1996, Nature Medicine.

[38]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[39]  P. Beverley,et al.  Is T-cell memory maintained by crossreactive stimulation? , 1990, Immunology today.

[40]  J. Hotchin.  The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. , 1962, Cold Spring Harbor symposia on quantitative biology.